Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C—Results of a Multicenter EpiTer-2 Study

The aim of the study was to analyze the effectiveness and safety of anti-HCV treatment based on a pangenotypic direct-acting antiviral (DAA) regimen with glecaprevir/pibrentasvir (GLE/PIB) in children. The multi-center study was conducted in HCV-infected children who were treated in the period from...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlowska, Malgorzata, Dobrowolska, Krystyna, Moppert, Justyna, Pokorska-Śpiewak, Maria, Purzynska, Mariola, Marczynska, Magdalena, Zarebska-Michaluk, Dorota, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647729/
https://www.ncbi.nlm.nih.gov/pubmed/37959413
http://dx.doi.org/10.3390/jcm12216949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647729/
https://www.ncbi.nlm.nih.gov/pubmed/37959413
http://dx.doi.org/10.3390/jcm12216949

Ejemplares similares